| Subject: | FDA Issues Notice of Voluntary Recall Notice for One Lot of Methylphenidate |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 4 Feb 2005 - 10:00 am |
| The FDA has notified healthcare professionals that Alliant Pharmaceuticals has voluntarily recalled of one lot of Methylphenidate HCl Chewable 5 mg Tablets. Methylphenidate (brand name: Ritalin) is a mild CNS stimulant and is prescribed for Attention Deficit Hyperactivity Disorder ADHD and Narcolepsy. Alliant found that one lot of the medication may contain up to three (3) times the amount of the medication's active ingredient, which may result in a serious health risk to patients.
Effected... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
